Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain
This article is from
The Cancer Letter
archive.
Vol. 19 No. 38 | October 1, 1993
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Time-Out For A New Sense Of Cooperation, Urgency.
January 21, 2000
TCL Archive
Democrats Say Bush Budget Neglects NSF And NASA.
March 23, 2001
TCL Archive
Illinois Center Organizes Regional Cooperative Group
June 16, 1978
TCL Archive
Funding Opportunities
October 11, 2002
TCL Archive
ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin
July 3, 1992
TCL Archive
Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy
March 28, 2008